Aerovate Therapeutics, Inc.
www.aerovatetx.comAerovate is a clinical stage biopharmaceutical company focused on developing drugs that meaningfully improve the lives of patients with rare cardiopulmonary disease. Aerovate's initial focus is on advancing AV-101, its dry powder inhaled formulation of the drug imatinib for the treatment of pulmonary arterial hypertension, or PAH.
Read more
Aerovate is a clinical stage biopharmaceutical company focused on developing drugs that meaningfully improve the lives of patients with rare cardiopulmonary disease. Aerovate's initial focus is on advancing AV-101, its dry powder inhaled formulation of the drug imatinib for the treatment of pulmonary arterial hypertension, or PAH.
Read more
Country
State
Massachusetts
City (Headquarters)
Boston
Industry
Employees
11-50
Founded
2018
Social
Employees statistics
View all employeesPotential Decision Makers
Senior Vice President Cmc
Email ****** @****.comPhone (***) ****-****Vice President Medical Affairs
Email ****** @****.comPhone (***) ****-****Senior Vice President Development Operations
Email ****** @****.comPhone (***) ****-****Chief Financial Officer
Email ****** @****.comPhone (***) ****-****
Technologies
(8)
Reach decision makers at Aerovate Therapeutics, Inc.
Free credits every month!
Aerovate Therapeutics, Inc. FAQ
Boston, United States
Biotechnology Research
